Officers & Duties

Brittany Baisch is a board-certified toxicologist in the Consumer Product Goods industry. She is currently the Research Fellow—Toxicology for Henkel’s North American laundry and home care products and was previously the Senior Toxicologist at The Kraft-Heinz Company. Her work involves toxicological risk assessments to substantiate safe use for consumers, which includes exposure modeling for various routes. She earned her PhD and MS in Toxicology from the University of Rochester and has BAs in Chemistry, Biochemistry and Spanish from Western Connecticut State University. Dr. Baisch is very active in the Society of Toxicology and has held several appointed and elected positions. She is very passionate about mentoring and providing support to trainees. She is currently the President Elect of Women in Toxicology (WIT), Vice President of Sustainable Chemicals through Contemporary Toxicology and the Junior Councilor for the Ethical, Legal, Forensics, and Societal Issues Specialty Sections. Dr. Baisch previously served as Secretary/Treasurer for Women in Toxicology, where her main focus was to increase the visibility of younger women in science by supporting the publication of many articles in the WIT newsletter. Also, she managed the WIT budget, which is one of the largest component group budgets within SOT, has co-led the proposal review and SOT award nomination subcommittees. Dr. Baisch also served as the Secretary/Treasurer of the newly formed Exposure Specialty Section, where she facilitated the establishment of awards, and assisting with recruiting a membership following and the augmentation of officer roles and responsibilities. She also served on the Education and Career Development Committee (ECDC), actively leading efforts to facilitate collaborations, mentorship and opportunities for scientists via the Global Senior Scholar Exchange, New Experiences in Toxicology and Supplemental Training Experience programs. She also actively served on committees to update the SOT Job Bank and to modify and execute the Triannual Toxicology Salary Survey. She also served on the Committee on Diversity Initiatives Undergraduate Peer Mentoring Program and various scientific program and award review committees within component groups. As an established toxicologist, Dr. Baisch has won several awards from her employer for leadership and delivering projects ahead of schedule, as well as within SOT for Paper of the Year and 1st place abstract from the Nanoscience and Contemporary Materials Specialty Section, and the Leadership Award and student travel awards from GSLC. Dr. Baisch is a strong supporter of building relationships between toxicologists and cross functional partners, which is of paramount importance in the food and consumer goods industries that she has worked.

Annie M. Jarabek serves as a Senior Science Advisor in the immediate office of the Center for Public Health and Environmental Assessment (CPHEA) at its Health and Environmental Effects Assessment Division (HEEAD) in the Research Triangle Park, within the US Environmental Protection Agency’s Office of Research and Development (ORD) following service as the Deputy Director of the Human Health Risk Assessment (HHRA) national research program. Annie has significant experience and post-graduate training in inhalation toxicology in both laboratory and clinical environments, dosimetry modeling, risk assessment, and decision analysis. She was principal author of the Agency’s Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, the first risk assessment methods to utilize physiologically based pharmacokinetic models. During her career at EPA, Annie has worked on risk assessments, dosimetry models or analysis methods across all media and routes of exposure. She was the lead for the Agency’s risk assessment of ingested perchlorate and other work addressed several priority interdisciplinary Agency assessments including the following: inhaled particulate matter, vinyl acetate, manganese, and Libby amphibole asbestos. Her current research efforts focus on multi-scale dosimetry modeling in support of advancing quantitative adverse outcome pathways (AOP) and integrated approaches to testing and assessment (IATA) for inhalation exposures. These efforts include approaches for in vitro to in vivo extrapolation (IVIVE) that ensure exposure alignment and translation across various experimental platforms to advance the application of novel approach methods (NAMs) and evidence integration for risk assessment. She recently led the development of technical support documentation and a user’s guide for the peer-reviewed EPA version of the multi-path particle dosimetry (MPPD) model which will serve as the basis for a computational and modular workflow that deploys various dosimetry models for inhaled agents across Agency risk assessments.

Active in the SOT, Annie was elected as president of the Risk Assessment Specialty Section (RASS) and to serve on the SOT Awards Committee. She was selected by SOT Council to serve on the Scientific Program Committee, the Strategic Communications committee, and Strategi Committee regarding the annual meeting. She was elected to serve as Vice President elect of the Women in Toxicology (WIT) special interest group in 2021. Annie is also active in the Society for Risk Analysis and was elected to serve as a Councilor to the SRA and appointed on many annual program committees in the past.

Annie serves frequently as an invited expert or to provide presentation on inhalation toxicology, dosimetry modeling or risk assessment. She has served on various workshops and numerous committees devoted to advancing risk assessment methods, and often is invited to organize or chair scientific sessions on emerging topics. Most recently, she was invited to organize and chair Modernization of Inhalation Risk Assessments at the 260th American Chemistry Society National Meeting and Exposition in 2020, and as a session chair for Dosimetry Modeling and Computational Approaches to Evidence Integration in 2018 at both the QEEN II: 2nd Quantifying Exposure to Engineered Nanomaterials from Manufactured Products Workshop and the Open Data Standards and Data Sharing Principles for Enabling Toxicology Collaborations workshop sponsored by OpenTox USA. She organized the jointly sponsored SOT-SRA contemporary concepts in toxicology (CCT) Workshop on Probabilistic Risk Assessment and the CCT Workshop entitled “Building for Better Decisions: Multi-scale Integration of Human Health and Environmental Data.” Currently Annie is serving on the scientific advisory board of the Advanced High Aspect Ratio and Multicomponent materials: towards comprehensive intelligent testing and Safe by design Strategies (HARMLESS) project under the Horizon 2020 initiative of the The EU Framework Programme for Research and Innovation, and to the Fraunhofer Institute of Toxicology and Experimental Medicine (Fraunhofer ITEM) in Hannover, Germany on Inhalation Toxicology and Chemical Risk Assessment. Invited presentations in 2021 included the keynote presentation to the Alliance for Risk Assessment’s annual meeting on Beyond Science and Decisions entitled “Transition to Translation: Mechanistic Modeling to Advance NAMs and Evidence Integration,” a webinar presentation within a workshop on Using In Silico and In Vitro Approaches for Next Generation Risk Assessment of Potential Respiratory Toxicants, a presentation to the International Society of Aerosols in Medicine (ISAM) at a workshop on safety evaluation of inhaled drugs, and a presentation entitled “Application of Mechanistic Data in Risk Assessment: Exposure Alignment and Evidence Integration” in a virtual workshop sponsored by the Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA)on Advancing Novel Approach Methods (NAMs) for Tobacco Harm Reduction. She also provides training on these topics within the Agency and to other regulatory organizations as well as lectures at UNC CH and Duke University.

Annie has authored over 50 peer-reviewed journal manuscripts and at least 100 Agency risk assessments. A manuscript on her collaborative inhalation IVIVE work received an honorable mention as the best 2018 paper from the Biological Modeling Specialty Section (BMSS) at the 2019 annual SOT meeting, and another on the integration of aggregate exposure pathways (AEP) and adverse outcome pathways (AOP) won best paper of the year from the Exposure Specialty Section (ExpoSS) of the SOT in 2020. Annie has also received three awards for best manuscript in risk assessment application from the Risk Assessment Specialty Section (RASS) of the SOT, along with several best abstract presentation awards. She received a Lifetime Achievement Award from the University of Massachusetts and the Risk Practitioner of the Year award from the Society of Risk Analysis (SRA). At the Agency, she has received the Superfund National Notable Achievement Award, several award medals (gold, silver, and bronze), a Pathfinder Innovation Project award, and multiple technical or special service awards. Annie was most recently honored with the Lehman award for risk assessment by the SOT in 2020.

Toufan Parman, PhD, DABT is the Senior Director of Nonclinical Safety Evaluations at Sangamo Therapeutics since February of 2021 where she leads the Pharmacology, Toxicology, and Pharmacokinetic Program. In this capacity she provides preclinical drug development strategy and safety assessment support for Sangamo’s wholly owned and partnered programs. Prior to Sangamo, she worked at SRI International (SRI) for 16 years where she managed the Mammalian Toxicology and Immunology Services group. At SRI, in addition to her management responsibilities, Dr. Parman was the Principal Investigator on four major NIH preclinical drug development and toxicology support contracts namely NICHD Biological Testing Facility (toxicology, and clinical manufacturing), NCI Pharmacology and Toxicology, NCI Prevent (toxicology, and immunology), and NCATS Support of the Therapeutics for Rare and Neglected Diseases (toxicology, and pharmacology). Under the NICHD contract she successfully moved two novel male contraceptives into clinical trials. Dr. Parman has over 20 years of experience in preclinical drug development translating novel therapeutics from discovery to clinic. She has managed, designed, developed, and conducted efficacy, general and reproductive toxicology, and PK studies as well as specialized mechanistic studies in various animal models for a wide variety of novel pharmaceutical products including but not limited to chemotherapeutic agents, anti-cancer vaccines, contraceptives, monoclonal antibodies, proteins, and gene and cell-based therapies. She has been certified by the American Board of Toxicology since 2007.

Dr. Parman believes in the mission of WIT which is to encourage women to pursue a career in toxicology and to mentor and provide leadership to support career growth of women in toxicology. Related to this, she has served as the Chair of K–12 outreach program for Northern California (NorCal) Chapter of SOT from 2011-2017 through which she worked with the Bay Area Girl Scouts and high schools to bring awareness to the science of toxicology to various age groups through hands on experiments, mentoring, and lectures for both students and parents. Dr. Parman has relevant past experience in successfully leading one of the largest and well-funded chapter of SOT. From 2013–2018, Dr. Parman served as the Treasurer, VP Elect, VP, President, and Past-President of NorCal SOT. With her past and current leadership experience Dr. Parman is committed to lead WIT to meet its objectives and mission.

Dr. Krisa Camargo, BS, PhD is a biologist with the US Army Public Health Center (APHC) where she works on multidisciplinary projects and provides consultative services regarding biological and toxicological topics. Dr. Camargo completed her PhD from Texas A&M University and also earned her Certificate in Homeland Security from the Texas A&M Bush School of Government & Public Service. Her doctoral work characterized contamination exposures and risk in soils and sediments within Galveston Bay (GB), the Houston Ship Channel (HSC), and Houston, TX by developing effective analytical tools and methods for disaster research. Her 2018 KC Donnelly Externship Supplemental Award afforded Dr. Camargo the opportunity to expand her research of rapid technologies for preliminary characterization of soil and sediment samples. Dr. Camargo is the primary author on three publications and co-author on 6 publications, one of which is a white paper with the Texas A&M Bush School of Government & Public Service. In addition to her research, Dr. Camargo has extensive volunteer experience in SOT where she has been a graduate peer-mentor for the SOT’s Diversity Initiatives Undergraduate Education Program since 2018 and she has served as the 2020–2021 GSLC Secretary. She has also served as the 2019 and 2020 MixSS Graduate Student Representative, helped edit and format several WIT Newsletters, and volunteered as a RSESS Session Proposal Reviewer since 2019. Dr. Camargo is interested in serving as WIT’s Secretary/Treasurer in part from her prior experiences volunteering for WIT’s newsletter as well as her love of writing. Dr. Camargo also has experience handling budgets of $5,000-$10,000 for both research projects (KC Donnelly Award) and student organization expenses (Aggies in Science Technology Engineering Policy). Dr. Camargo’s training through the TAMU Toxicology and Superfund programs have ultimately prepared her to work in interdisciplinary settings and have facilitated her efforts to build networks for both research and outreach efforts related to toxicology.

Dr. Sulentic is currently an Associate Professor within the Department of Pharmacology & Toxicology at Wright State University, Boonshoft School of Medicine. Prior to joining the faculty at Wright State in November 2003, she received her doctorate in Pharmacology & Toxicology at Michigan State University in 1999 and was a postdoctoral fellow in the laboratory of Dr. Norbert Kaminski at Michigan State University from 1999-2003, where she was funded under an NIEHS National Research Service Award. Her research is currently funded by NIH. Along with past NIEHS funding she has received several intramural grants as well as the Colgate-Palmolive Grant for Alternative Research from SOT. Her overall research goal is to elucidate, at the cellular and molecular level, the human health implications of altered antibody expression by xenobiotics such as the environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin, and the role of specific genetic factors in influencing individual susceptibility to xenobiotics. Dr. Sulentic has served on the Immunotoxicology Expert Panel for EPA’s Dioxin Workshop (2009) and on grant review panels for the NIEHS Superfund Research Program (2016 and 2011) and the R13/U13 Conference Grants (2015) and for the Natural Sciences and Engineering Research Council of Canada (2015). She is author/co-author of 29 peer-reviewed articles and book chapters. Dr. Sulentic has been very active in training undergraduate and graduate students and is involved in professional societies including the American Society for Pharmacology and Experimental Therapeutics, the American Association of Immunologist and particularly SOT and the Ohio Valley SOT regional chapter.

She has been a member of the SOT since 1995 and has served the SOT in the following capacities: Career Resource and Development Committee 2010–2013, Co-Chair 2011–2012, Chair 2012–2013; Continuing Education Committee 2007–2010; Undergraduate Strategy Work Group/Task Force 2014–2017; Education Summit Organizing Team 2010–2012; Regional Chapter Collaboration and Communication Committee 2011–2013; SOT Women in Toxicology Mentoring Initiative 2011-2012; SOT Mentoring Match program organizer and facilitator 2012–2014; Ohio Valley Regional Chapter 2002–present, Secretary 2006–2009, Vice President 2009–2010, President-Elect 2010–2011, President 2011–2012, Past President 2012–present; Women in Toxicology Special Interest Group 1995–present; Immunotoxicology Specialty Section 1996–present, Steering Committee for a Regional Immunotoxicology Meeting 2011–2012, Awards Committee 2007–2008; Molecular Biology Specialty Section 2006–present; Colgate-Palmolive Grant for Alternative Research 2006; SOT Elected Positions include Awards Committee 2016–2018, Co-Chair 2016–2017, Chair 2017–2018 and Councilor 2018–2021.

Carmen Rubio Armendáriz, Ph.D. (USA, 1973)

She is a member of the U.S. Society of Toxicology (SOT) since 2018 and has served on the Executive Committee of the Hispanic Organization of Toxicologists (HOT) (2019–2021), where she was chair of the Award, Education and Global Outreach Committees. She is the junior Councilor of the Women in Toxicology (WIT)-SIG since 2021. She is also a member of the Society of Toxicology of Canada (STC) and the Spanish Association of Toxicology (AETOX).

Associate Professor (tenured) of Toxicology at the University of La Laguna since 2009. Her education includes a Pharmacy bachelor’s degree (1996), a Food Science and Technology bachelor’s degree (2001), a Master in Pharmaceutical Care (1999), a Master of Toxicology and Food Safety (2006), a Master in Health Education (2007), a Ph.D. in Basic and Applied Toxicology, a Leading Organizations and Change Diploma (MIT-Sloan) and a University Policy and Management Postgraduate Diploma. Among other prizes, she won the Award for Young Researchers in the Medical and Health Sciences branch from the Canary Islands Government (2002) and the Outstanding 2020 HOT (Hispanic Organization of Toxicologist)-SIG Award.

As a Senior Research Fellow, her research is focused on Food Safety and Risk Assessment. She has participated in 14 research projects and directed 15 doctoral theses. Prof Rubio is the author and/or co-author of more than 90 articles in high-impact journals, a reviewer for several journals, international research programs, grants, and national and international PhDs. She was also a member of the Scientific Committee on Food Safety of the Spanish Agency for Food Safety and Nutrition (AESAN) of the Ministry of Health, Consumption and Social Welfare (2017–2021).

She served in a senior academic policy and management role as Vice-Chancellor for Internationalization of the University of La Laguna (2015–2019), member of the university Council and Senate, and director of the Institutional Chair in Healthcare Pharmacy (2018–2019). Her enthusiasm for global networking offered her the opportunity to be appointed president of the Working Group on Internationalization of CRUE (Conference of Principals of 76 Spanish Universities) and a member of CRUE executive committee for Internationalization and Cooperation (2017–2019). She also served as the councilor for research of the Official College of Pharmacists in the province of Santa Cruz de Tenerife (2004–2018).

Dr. Rubio Armendáriz’s stands for her leadership experiences. She is a team player with the ability to build the best strategy to join diverse backgrounds and expertise to accomplish a common goal. Her social commitment made her become co-founder of the USF (Universidad sin Fronteras) Association in 2020 being the Vice President since then.

Dr. Buha Djordjevic is an assistant professor at the Faculty of Pharmacy, University of Belgrade, where she teaches toxicology to undergraduate and PhD students. Also, she conducts research in the field of mixture toxicology and endocrine disrupting chemicals, mainly on animal models. She is the PI of the national project “Decoding the role of exposome in human endocrine health” funded by The Science Fund of the Republic of Serbia. She serves as MC member and science communication coordinator for the COST action CA 20121 “Bench to bedside transaction for pharmacological regulation of NRF2 in noncommunicable diseases.”

In the period between 2016 and 2018, she was a co-principal investigator on a project Establishing polysilicate pro-inflammatory effectiveness and toxicity in vivo in collaboration with MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, UK and Faculty of Veterinary Medicine, University of Cambridge, UK (co-principal investigator from UK Prof Dr Jonathan J. Powell).

She received her Postgrad Specialism in Toxicological Risk Assessment in 2014 and doctorate in the field of mixture toxicology from Faculty of Pharmacy, University of Belgrade in 2016. In 2015 she was a visiting scholar in Biomineral research group, MRC Elsie Widdowson Laboratory, Cambridge, UK. She became European Registered Toxicologist in 2019.

Dr. Buha Djordjevic has served as the Secretary General of the Serbian Congress of Toxicology, in 2014, then as a member of Scientific Committee of 10th Congress of Toxicology in Global Economy Country List (CTDC10) organized under the auspice of IUTOX in 2018. Currently she serves as a Secretary General of International Society for Research on Cadmium and Trace Element Toxicity, member of the HEEDS Consortium, member of the EDCs Working Group of European Society of Endocrinology, member of the Committee on Research Initiatives & Excellence of The Intersectoral Centre for Endocrine Disruptor Analysis, and President of Belgrade Pharmaceutical Association. She is a regular reviewer for many peer-reviewed journals and was awarded as Top Peer Reviewer in the Global Peer Review Awards 2019 by Web of Science. Dr. Buha Djordjevic is a member of the Toxicology Reports Editorial board and associate editor of All life journal.

She is author/co-author of more than 60 peer-reviewed publications, her h index is 21 and her work has been cited more than 1,400 times according to SCOPUS. Dr. Buha Djordjevic has been included in the Stanford University list of top two-percent scientists in the world for 2020.

She has been a member of the SOT since 2019 and has served the SOT as the member of Women in Toxicology Proposal Committee.

Dr. Walker is a Postdoctoral Fellow at Rutgers University where she studies how environmental chemicals negatively affect the ability of type of immune cells to defend the placenta from infections. She received her doctorate in Environmental Toxicology from the University of California, Riverside in 2019. Dr. Walker has been a member of SOT since 2015. As a graduate student, Dr. Walker served as a SOT student representative from 2016–2019 in the following roles: Student Representative (Women in Toxicology), Professional Development Subcommittee Secretary (Graduate Student Leadership Committee), and Professional Development Subcommittee Chair (Graduate Student Leadership Committee). Outside of SOT, Dr. Walker is the Vice-Chair of the Diversity, Equity, and Inclusion Committee for the Federation of American Societies for Experimental Biology (FASEB) and is an Early Career Representative of the Public Affairs Committee for the Society for Birth Defects Research and Prevention (BDRP).

Danielle Kozlosky, BS is currently pursuing her PhD in Toxicology as part of the Joint Graduate Program in Toxicology (JGPT) at Rutgers University through the lab of Dr. Lauren Aleksunes. For her thesis work, she investigates the in vivo protective role of a placental transporter protein against cadmium-induced placental toxicity resulting in poor fetal growth and nutrition. In September 2020, she was awarded three-years of funding through her own NIH/NIEHS F31 fellowship. Further, Danielle continually seeks to continue her passions for pathology through combine cutting-edge digital tools to study placental and fetal toxicologic pathology.

Danielle has a strong passion for advocating topics of concern for current graduate students. She has previously served (2020–2021) the executive board position of Secretary for the Rutgers University Graduate Student Association (GSA). Through this position, she hosted Town Hall meetings with the Rutgers President and other essential personnel, as well as joined the national coalition “Students Advocating for Graduate Education” (SAGE) where she served as Vice President. Danielle currently serves as a Rutgers University School of Graduate Studies Student Senator where she advocates concerns of current Rutgers graduate students to the university administration, chancellors, and president.

Danielle has a desire for involvement and mentorship. She is an active student member of SOT, her regional chapter (MASOT), and the middle Atlantic Reproduction and Teratology Association (MARTA). As a member of MASOT, she actively participates on the Program Committee, and is finishing up her two-year term of MASOT Graduate Student Representative. Danielle is also finishing up her role as Graduate Student Representative for the SOT Clinical and Translational toxicology specialty section (2020–2022).

As WIT Graduate Student Representative, Danielle plans to further her involvement and mentorship role in SOT. Through this role, she hopes to help expand student involvement in the current trend of increased scientific and career mentoring, as well as in the educational activities of this special interest group.